The role of asymmetric and symmetric dimethylarginines in renal disease.
about
Systematic review regarding metabolic profiling for improved pathophysiological understanding of disease and outcome prediction in respiratory infectionsNitric oxide synthase derangements and hypertension in kidney diseaseThe role of drug transporters in the kidney: lessons from tenofovirVascular effects of exercise training in CKD: current evidence and pathophysiological mechanismsAsymmetric dimethylarginine and cardiovascular risk: systematic review and meta-analysis of 22 prospective studiesSerum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney DiseaseRelationship between lean body mass and serum renal biomarkers in healthy dogsAsymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)Incidence of all-cause and cardiovascular mortality predicted by symmetric dimethylarginine in the population-based study of health in pomerania.Restoration of asymmetric dimethylarginine-nitric oxide balance to prevent the development of hypertension.Dimethylarginines: endogenous inhibitors of nitric oxide synthesis in children with falciparum malaria.Symmetric dimethylarginine as predictor of graft loss and all-cause mortality in renal transplant recipientsHomoarginine and mortality in pre-dialysis chronic kidney disease (CKD) patientsEndothelial dysfunction and brachial intima-media thickness: long term cardiovascular risk with claudication related to peripheral arterial disease: a prospective analysis.Plasma symmetric dimethylarginine reference limits from the Framingham offspring cohort.Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis--a randomized cross-over study.Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Cats.Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric DogsDietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats.Arginines Plasma Concentration and Oxidative Stress in Mild to Moderate COPD.Asymmetric and Symmetric Dimethylarginine as Risk Markers for Total Mortality and Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of Prospective StudiesIncreased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction.Serum concentrations of symmetric dimethylarginine and creatinine in cats with kidney stonesApolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function.Endothelin-A receptor antagonism modifies cardiovascular risk factors in CKD.Plasma metabolomic profiles in different stages of CKD.Comparison of serum concentrations of symmetric dimethylarginine and creatinine as kidney function biomarkers in cats with chronic kidney disease.Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.Small Molecule Inhibitors of Protein Arginine Methyltransferases.Diabetes-linked transcription factor HNF4α regulates metabolism of endogenous methylarginines and β-aminoisobutyric acid by controlling expression of alanine-glyoxylate aminotransferase 2Admission levels of asymmetric and symmetric dimethylarginine predict long-term outcome in patients with community-acquired pneumonia.ADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiographyChronic kidney disease and vascular remodelling: molecular mechanisms and clinical implications.Cardiovascular disease in chronic kidney disease: untying the Gordian knot.Role of asymmetrical dimethylarginine in the progression of renal disease.Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.The endothelial ADMA/NO pathway in hypoxia-related chronic respiratory diseases.AGXT2: a promiscuous aminotransferase.Asymmetric Dimethylarginine Predicts Long-Term Outcome in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
P2860
Q26782662-7957C7A3-7B37-4224-8774-3CFEE9237F1FQ26849234-7C921BE0-AEE7-4F0E-B5A7-76BACEFE57E1Q26866489-15D48A47-6091-45E6-819C-78EF6FD4764EQ27021802-5B021F92-AD61-4BFD-A56E-BFA222CD89C0Q28087272-74656A78-E8D2-4C38-848E-92D45313E0BFQ28601037-E9D92A84-3863-470D-B61A-BC977838D3CFQ28601638-21887B76-4AAB-45FE-A841-FEC7992627A5Q33580586-6474F827-F45E-4003-8DA6-C160435E3E75Q33599633-011DD008-3FA4-4FE8-9D20-6AC0D1DFD875Q34072296-6AEADC93-3D25-4964-BBD7-35F2A2CEA283Q34315639-EBA3E6BE-19DF-4E35-BA41-1DE0457ACF93Q34556614-3E5F7C6D-C1DF-4167-85DE-B4A6B0F797DCQ34984003-6BDE2754-DA5D-4F70-9FA6-431B3A3C1239Q35150499-0BFC8388-D01D-45C4-94EC-252AC528723FQ35607229-BC33656E-BDC0-4594-8031-46F87E4B0F6BQ35686992-C1AD4526-5D29-42B9-8CD0-A988E4930244Q35818228-A8F5256E-39A9-447A-82D5-8BA0F91D2B98Q35990048-5C973F0F-8D48-4EAB-B305-2D42C50A690DQ35992197-69E828A0-CFA3-485D-99C7-00811F2D1EBCQ36082389-B1B5170C-A12D-44E7-B6C6-A20717F20898Q36091725-70EA8B12-1048-4FB9-ADDF-1DD7D8C337B7Q36182184-EB784EDC-BD35-4843-ACC7-B3774A83D810Q36260985-E79F08CB-A435-4E41-B6A0-F79E52F42944Q36337929-AC5CF47D-9EC7-4156-9A2F-510FE6CE2FB5Q36481807-6736F45C-5E59-4681-BAF7-F950BC8539FDQ36509293-196826E4-EA38-4570-AB8E-8C4E053B3127Q36652795-A38C0E58-DDD1-413C-B2B8-B9022C32B6D9Q36975461-1C9B1201-A6D6-41BF-AB7A-AA31A4D0A607Q37015522-1A0AB2C4-A504-4BD3-B750-8D420DCB5846Q37056442-0B521028-05CC-4062-9592-E2B80845C973Q37345580-81BE1484-7417-4EF7-95AE-B184429F0536Q37602513-A647FBC9-99EA-4C30-96A7-A2669395BD9AQ37646687-E3747AC2-0921-4AED-82DD-1BD0FBDA1FEFQ38016491-2ADDEFDC-3957-48A6-BB5D-62263366544EQ38025185-3BA53C82-AA26-431C-9EEC-FD1C7E4EF30EQ38046935-2CAF5253-3B6F-4383-A8AD-6E002B8845ADQ38112398-30BA5EE3-9FF4-4084-A2EC-E4691480CF74Q38203518-20EEB485-00DE-42FC-A72B-F9D4CF6537CFQ38257983-11CD4D0E-7B7E-44C5-B5BE-13802AAC8040Q38635782-5101F06E-ED28-443A-9413-000D9D7A5FF9
P2860
The role of asymmetric and symmetric dimethylarginines in renal disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of asymmetric and symmetric dimethylarginines in renal disease.
@en
The role of asymmetric and symmetric dimethylarginines in renal disease.
@nl
type
label
The role of asymmetric and symmetric dimethylarginines in renal disease.
@en
The role of asymmetric and symmetric dimethylarginines in renal disease.
@nl
prefLabel
The role of asymmetric and symmetric dimethylarginines in renal disease.
@en
The role of asymmetric and symmetric dimethylarginines in renal disease.
@nl
P2860
P356
P1476
The role of asymmetric and symmetric dimethylarginines in renal disease.
@en
P2093
Edzard Schwedhelm
Rainer H Böger
P2860
P2888
P304
P356
10.1038/NRNEPH.2011.31
P407
P577
2011-03-29T00:00:00Z
P6179
1020331026